Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.

May, Andreas E

Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. [electronic resource] - Thrombosis and haemostasis Mar 2008 - 487-93 p. digital

Publication Type: Journal Article; Review

0340-6245

10.1160/TH07-11-0680 doi


Algorithms
Angioplasty, Balloon, Coronary--adverse effects
Anticoagulants--therapeutic use
Aspirin--adverse effects
Blood Coagulation--drug effects
Clopidogrel
Drug Resistance
Evidence-Based Medicine
Fibrinolytic Agents--adverse effects
Hemorrhage--blood
Humans
Patient Selection
Perioperative Care
Platelet Aggregation Inhibitors--adverse effects
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Stents
Thrombosis--blood
Ticlopidine--adverse effects